Clinical Trials Directory

Trials / Completed

CompletedNCT04232033

The Physiological Effects of FGF21 on Alcohol Preference and Glucose Metabolism

The Physiological Effects of FGF21 on Alcohol Preference and Glucose Metabolism in Healthy Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

The primary objective is to evaluate taste preferences for alcohol during an intravenous infusion of the naturally occurring hormone fibroblast growth factor-21 (FGF21) and placebo (i.e. saline), respectively, in 20 healthy subjects. Secondary endpoints are to evaluate the effects of exogenous FGF21 (compared to placebo) on resting energy expenditure, preference for salt, sour and bitter taste qualities, sensations of hunger, thirst, appetite, satiety, headache and nausea, and makers of glucose metabolism (e.g. plasma/serum concentrations of glucose, C-peptide, insulin and glucagon).

Conditions

Interventions

TypeNameDescription
OTHERFibroblast growth factor 21 infusionInfusion of Fibroblast growth factor 21
OTHERPlacebo infusion (saline)Infusion of Saline

Timeline

Start date
2021-05-01
Primary completion
2022-06-14
Completion
2024-12-01
First posted
2020-01-18
Last updated
2024-12-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04232033. Inclusion in this directory is not an endorsement.